Funder: Novartis
Due Dates: March 2, 2026 (Applications due to Novartis for the ITP RFP, 5 PM EST)
Funding Amounts: Up to $400,000 total support available for 2026; single- or multi-support initiatives possible.
Summary: Supports innovative, independent medical education programs to advance healthcare provider knowledge and patient care in Immune Thrombocytopenic Purpura (ITP).
Key Information: Applications must be US-focused and submitted via Novartis Grants Central Station; collaborations with non-profits are preferred.